Lantheus Holdings (LNTH) Curent Deferred Tax Liability (2014 - 2015)
Lantheus Holdings' (LNTH) quarterly Curent Deferred Tax Liability came in at $194000.0 in Q4 2015, up 27.63% year-on-year from $152000.0 in Q4 2014, and up 27.63% on a QoQ basis from $152000.0 in Q4 2014.
Lantheus Holdings (LNTH) Curent Deferred Tax Liability (2014 - 2015) Analysis & Trends
Lantheus Holdings (LNTH) has 2 years of Curent Deferred Tax Liability data on file, last reported at $194000.0 in Q4 2015.
- On a quarterly basis, Curent Deferred Tax Liability rose 27.63% year-over-year to $194000.0 in Q4 2015; TTM through Dec 2015 was $194000.0, a 27.63% increase from a year earlier, with the FY2015 full-year figure at $194000.0, up 27.63% from the prior year.
- Curent Deferred Tax Liability for Q4 2015 stood at $194000.0, up from $152000.0 in the prior quarter.
- Over the last five years, Curent Deferred Tax Liability for LNTH reached as high as $194000.0 in Q4 2015 and fell as low as $152000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 194,000.00 |
| Dec 31, 2015 | 194,000.00 |
| Dec 31, 2014 | 152,000.00 |
| Dec 31, 2014 | 152,000.00 |